2 leading Ebola vaccines appear safe, further tests starting
28.1.15
Add Comment
2 leading Ebola vaccines appear safe, further tests starting
After an expert meeting this week, WHO said there is now enough information to conclude that the two most advanced Ebola vaccines - one made by GlaxoSmithKline and the other licensed by Merck and NewLink - have "an acceptable safety profile.".
Read more on Bay News 9
Berkeley cancer drug developer Aduro BioTech snags million
Aduro BioTech Inc.'s vaccine approach to whipping tough-to-treat cancers brought in $ 51.4 million in a Series D round of funding. The preferred stock financing, which brought the Berkeley company's total 2014 fundraising to $ 106.4 million, consisted of ...
Read more on San Francisco Business Times (blog)
After an expert meeting this week, WHO said there is now enough information to conclude that the two most advanced Ebola vaccines - one made by GlaxoSmithKline and the other licensed by Merck and NewLink - have "an acceptable safety profile.".
Read more on Bay News 9
Berkeley cancer drug developer Aduro BioTech snags million
Aduro BioTech Inc.'s vaccine approach to whipping tough-to-treat cancers brought in $ 51.4 million in a Series D round of funding. The preferred stock financing, which brought the Berkeley company's total 2014 fundraising to $ 106.4 million, consisted of ...
Read more on San Francisco Business Times (blog)
0 Response to "2 leading Ebola vaccines appear safe, further tests starting"
Post a Comment